Momenta Pharmaceuticals announces proposed public offering of common stock
Momenta Pharmaceuticals announced that it is commencing an underwritten registered public offering of $150,000,000 of shares of its common stock. Momenta also expects to grant underwriter an option to purchase up to an additional $22,500,000 of shares of its common stock. December 05, 2018